Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

DBV Technologies (DBVT) Current Taxes (2015 - 2018)

DBV Technologies (DBVT) reported Current Taxes of $511345.6 for Q4 2018, up 1.47% year-over-year from $503941.1 in Q4 2017, and up 1.47% on a QoQ basis from $503941.1 in Q4 2017.

DBV Technologies (DBVT) has 4 years of Current Taxes data on file, last reported at $511345.6 in Q4 2018.

  • Quarterly Current Taxes rose 1.47% year-over-year to $511345.6 in Q4 2018, while the trailing twelve-month figure through Dec 2018 was $511345.6 (up 1.47% YoY) and the FY2018 annual result came in at $511345.6, up 1.47% from the prior year.
  • Current Taxes advanced to $511345.6 in Q4 2018 per DBVT's latest filing, from $503941.1 in the prior quarter.
  • Across five years, Current Taxes topped out at $544181.0 in Q4 2016 and bottomed at $425293.5 in Q4 2015.
  • The 4-year median for Current Taxes is $507643.4 (2017), against an average of $496190.3.
  • The widest annual swing landed in 2016, when Current Taxes rose 27.95%; it then decreased 7.39% in 2017.
  • Tracing DBVT's Current Taxes over 4 years: stood at $425293.5 in 2015, then gained by 27.95% to $544181.0 in 2016, then declined by 7.39% to $503941.1 in 2017, then increased by 1.47% to $511345.6 in 2018.
  • Per Business Quant, the three latest DBVT Current Taxes figures stand at $511345.6 (Q4 2018), $503941.1 (Q4 2017), and $544181.0 (Q4 2016).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Taxes (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - 10,460.56
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 19.20 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn -
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn -
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn -
10 DBV Technologies 8.00 Bn 7.77 Bn -3.90 Mn -

Historic Data

Download Data 🔒
DateValue
Dec 31, 2018 511,345.60
Dec 31, 2017 503,941.12
Dec 31, 2016 544,181.01
Dec 31, 2015 425,293.50